TailorMed and Tennr have announced a platform integration designed to connect referral automation with medication affordability support for infusion centers and specialty pharmacies. The partnership pairs Tennr’s referral intake, documentation review, and
More
The FDA has approved the Padcev and Keytruda combination as the first platinum-free regimen for adult patients with muscle-invasive bladder cancer, regardless of cisplatin eligibility. The landmark approval marks a significant territorial
More
Pharmacy benefit manager reform is changing the commercial and operational environment for pharmaceutical manufacturers, even where it stops short of imposing direct obligations on them. Manufacturer programs do not operate in isolation,
More
AstraZeneca faced fresh pressure on the London markets after a clinical trial failure weighed heavily on investor sentiment across the FTSE 100 index. The pharmaceutical giant, listed on the London Stock Exchange
More
The US Court of Appeals for the Federal Circuit has affirmed a district court’s claim construction and grant of a preliminary injunction in a pharmaceutical patent case. The ruling came in Otsuka
More
The FTSE 100 outperformed the S&P 500 in 2025, returning 21.5% versus 16.2%, despite containing almost no pure-play artificial intelligence stocks. While global investors pour money into Nvidia and Microsoft, traditional UK
More
AstraZeneca plc (LON: AZN) fell 1.3 percent and GSK plc (LON: GSK) dropped 1.5 percent on Tuesday April 21, making the pharmaceutical sector the weakest performer in the FTSE 100 as investors
More
Australia-based biotech Propanc Biopharma has announced a major step into the digital asset space with plans to establish a crypto treasury. The company revealed it has secured up to $100 million from
More
The U.S. Food and Drug Administration (FDA) recently withheld approval for a novel once-a-month injection designed to treat relapsing forms of multiple sclerosis (MS), a severe neurological disorder. This decision impacts the
More